GlassScriptPhysician profile
Deborah C Scally
NPI 1831634625
$4,345.13
in general payments reported to CMS, 2019-2025
33 companies · $933 in 2025
The $933 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,007 · 2022: $828 · 2023: $846 · 2024: $732 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,468 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.06 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $786.56 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $669.70 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.55 | 2021-2023 | Jardiance |
| Abbott Laboratories | $239.93 | 2021-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $238.71 | 2021-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $229.11 | 2021-2023 | Farxiga |
| Xeris Pharmaceuticals, INC. | $164.63 | 2021-2025 | Gvoke Hypopen |
| Recordati_rare_diseases_inc. | $157.82 | 2025 | Isturisa |
| Corcept Therapeutics | $156.18 | 2024-2025 | Korlym |
| Abbvie INC. | $142.33 | 2021 | |
| Insulet Corporation | $141.19 | 2024-2025 | Omnipod |
| Teva Pharmaceuticals USA, INC. | $121.74 | 2022 | |
| Sk Life Science, INC. | $117.72 | 2021 | |
| Idorsia Pharmaceuticals US INC | $112.86 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $104.02 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $78.98 | 2021-2025 | |
| Tandem Diabetes Care, INC. | $68.26 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $64.24 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Mannkind Corporation | $60.48 | 2025 | |
| Sanofi-Aventis U.S. LLC | $59.86 | 2021-2022 | |
| Cequr Corporation | $55.55 | 2024-2025 | Cequr Simplicity |
| Sage Therapeutics, LLC | $54.59 | 2023 | |
| Janssen Pharmaceuticals, INC | $32.26 | 2022-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $31.51 | 2021 | |
| Bigfoot Biomedical INC | $23.84 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.66 | 2023 | Ultomiris |
| Sequel Med Tech, LLC | $18.90 | 2025 | Twiist |
| Medtronic, INC. | $18.13 | 2024 | Minimed 780g |
| Vivus LLC | $17.72 | 2022 | |
| Glaxosmithkline, LLC. | $16.08 | 2022 | |
| Ascensia Diabetes Care US INC. | $15.89 | 2025 | |
| Amarin Pharma, INC. | $13.04 | 2021 | |
| Currax Pharmaceuticals LLC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Scally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.